OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Blockage of the IL-31 Pathway as a Potential Target Therapy for Atopic Dermatitis
Raquel Leão Orfali, Valéria Aoki
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 577-577
Open Access | Times Cited: 20
Raquel Leão Orfali, Valéria Aoki
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 577-577
Open Access | Times Cited: 20
Showing 20 citing articles:
Investigating the efficacy of mirtazapine-embedded invasomal gel nanocarriers via I-optimal design for management of atopic dermatitis
Tarek Ibrahim, Nourhan A. Abdulla, Mai A. Mohamed
Journal of Drug Delivery Science and Technology (2024) Vol. 92, pp. 105395-105395
Closed Access | Times Cited: 7
Tarek Ibrahim, Nourhan A. Abdulla, Mai A. Mohamed
Journal of Drug Delivery Science and Technology (2024) Vol. 92, pp. 105395-105395
Closed Access | Times Cited: 7
Precision Dermatology: A Review of Molecular Biomarkers and Personalized Therapies
Isabella J. Tan, Alicia Podwójniak, Aarushi K. Parikh, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 4, pp. 2975-2990
Open Access | Times Cited: 7
Isabella J. Tan, Alicia Podwójniak, Aarushi K. Parikh, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 4, pp. 2975-2990
Open Access | Times Cited: 7
Potential Aspects of the Use of Cytokines in Atopic Dermatitis
Magdalena Krupka, Andrzej Bożek, David Aebisher, et al.
Biomedicines (2024) Vol. 12, Iss. 4, pp. 867-867
Open Access | Times Cited: 5
Magdalena Krupka, Andrzej Bożek, David Aebisher, et al.
Biomedicines (2024) Vol. 12, Iss. 4, pp. 867-867
Open Access | Times Cited: 5
The evolving therapeutic landscape in atopic dermatitis
Luis Angel Hernández-Zárate, Carlos Andrés Gómez-Núñez, Stefan Narváez-Labuhn, et al.
(2025) Vol. 3
Closed Access
Luis Angel Hernández-Zárate, Carlos Andrés Gómez-Núñez, Stefan Narváez-Labuhn, et al.
(2025) Vol. 3
Closed Access
Exploring itch in hidradenitis suppurativa with lessons from atopic dermatitis and psoriasis
Nicole Trupiano, Kelly Z. Young, Harika Echuri, et al.
The Journal of Dermatology (2025)
Closed Access
Nicole Trupiano, Kelly Z. Young, Harika Echuri, et al.
The Journal of Dermatology (2025)
Closed Access
Type 2 Inflammation and Its Role in Dermatologic Diseases
Raj Chovatiya, Jason E. Hawkes, Douglas DiRuggiero, et al.
International Journal of Dermatology (2025)
Open Access
Raj Chovatiya, Jason E. Hawkes, Douglas DiRuggiero, et al.
International Journal of Dermatology (2025)
Open Access
Novel Therapeutic Targets for the Treatment of Atopic Dermatitis
Gaku Tsuji, Kazuhiko Yamamura, Koji Kawamura, et al.
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1303-1303
Open Access | Times Cited: 11
Gaku Tsuji, Kazuhiko Yamamura, Koji Kawamura, et al.
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1303-1303
Open Access | Times Cited: 11
The IL-33/IL-31 Axis in Allergic and Immune-Mediated Diseases
Giuseppe Murdaca, Sebastiano Gangemi, Mónica Greco
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9227-9227
Open Access | Times Cited: 10
Giuseppe Murdaca, Sebastiano Gangemi, Mónica Greco
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9227-9227
Open Access | Times Cited: 10
Basophils in pruritic skin diseases
Daniela Wiebe, Maren M. Limberg, Natalie Gray, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Daniela Wiebe, Maren M. Limberg, Natalie Gray, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Monoclonal antibodies for moderate-to-severe atopic dermatitis: a look at phase III and beyond
Eden David, Kelly Hawkins, Neda Shokrian, et al.
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 6, pp. 471-489
Closed Access | Times Cited: 3
Eden David, Kelly Hawkins, Neda Shokrian, et al.
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 6, pp. 471-489
Closed Access | Times Cited: 3
Cholestatic Pruritus: Pathophysiology, Current Management Approach, and Emerging Therapies
Vishwajit Kode, Kidist Yimam
Current Hepatology Reports (2024) Vol. 23, Iss. 1, pp. 123-136
Open Access | Times Cited: 2
Vishwajit Kode, Kidist Yimam
Current Hepatology Reports (2024) Vol. 23, Iss. 1, pp. 123-136
Open Access | Times Cited: 2
Novel therapeutic receptor agonists and antagonists in allergic conjunctivitis
Sampson Listowell Abu, Navpreet K. Hehar, DeGaulle I. Chigbu
Current Opinion in Allergy and Clinical Immunology (2024) Vol. 24, Iss. 5, pp. 380-389
Closed Access | Times Cited: 1
Sampson Listowell Abu, Navpreet K. Hehar, DeGaulle I. Chigbu
Current Opinion in Allergy and Clinical Immunology (2024) Vol. 24, Iss. 5, pp. 380-389
Closed Access | Times Cited: 1
Critical role of keratinocytes in cutaneous immune responses
Rakesh Kumar Gupta, Poonam Wasnik, Deepankar Mondal, et al.
Exploration of Immunology (2024) Vol. 4, Iss. 4, pp. 502-522
Open Access | Times Cited: 1
Rakesh Kumar Gupta, Poonam Wasnik, Deepankar Mondal, et al.
Exploration of Immunology (2024) Vol. 4, Iss. 4, pp. 502-522
Open Access | Times Cited: 1
Inhibidores de JAK en dermatitis atópica, nuevas perspectivas
M. Munera-Campos, J.M. Carrascosa
Actas Dermo-Sifiliográficas (2023) Vol. 114, Iss. 8, pp. 680-707
Open Access | Times Cited: 3
M. Munera-Campos, J.M. Carrascosa
Actas Dermo-Sifiliográficas (2023) Vol. 114, Iss. 8, pp. 680-707
Open Access | Times Cited: 3
[Translated article] Janus Kinase Inhibitors in Atopic Dermatitis: New Perspectives
M. Munera-Campos, J.M. Carrascosa
Actas Dermo-Sifiliográficas (2023) Vol. 114, Iss. 8, pp. T680-T707
Open Access | Times Cited: 3
M. Munera-Campos, J.M. Carrascosa
Actas Dermo-Sifiliográficas (2023) Vol. 114, Iss. 8, pp. T680-T707
Open Access | Times Cited: 3
A review of catechins and their use in atopic dermatitis
Emma Beagles, Ethan A. Lerner
Itch (2024) Vol. 9, Iss. 4
Closed Access
Emma Beagles, Ethan A. Lerner
Itch (2024) Vol. 9, Iss. 4
Closed Access
733 - Nemolizumab elicits fast itch response in atopic dermatitis within 2 days: a post hoc analysis of ARCADIA 1 and 2 data
Jonathan I. Silverberg, Linda Stein‐Gold, Diamant Thaçi, et al.
British Journal of Dermatology (2024) Vol. 191, Iss. Supplement_2
Closed Access
Jonathan I. Silverberg, Linda Stein‐Gold, Diamant Thaçi, et al.
British Journal of Dermatology (2024) Vol. 191, Iss. Supplement_2
Closed Access
The role of nemolizumab in the treatment of atopic dermatitis for the adult population
Stuti Prajapati, Joseph P Flemming, Danyaal Khan, et al.
Immunotherapy (2024) Vol. 16, Iss. 14-15, pp. 925-935
Closed Access
Stuti Prajapati, Joseph P Flemming, Danyaal Khan, et al.
Immunotherapy (2024) Vol. 16, Iss. 14-15, pp. 925-935
Closed Access
Th Pathways in Immune-Mediated Skin Disorders: A Guide for Strategic Treatment Decisions
Reinhart Speeckaert, Arno Belpaire, Jo Lambert, et al.
Immune Network (2024) Vol. 24, Iss. 5
Open Access
Reinhart Speeckaert, Arno Belpaire, Jo Lambert, et al.
Immune Network (2024) Vol. 24, Iss. 5
Open Access
Biologics and Small Molecules for Inflammatory Nail Disorders: A Narrative Review
Carrie A. Forman, Shari R. Lipner
Indian Dermatology Online Journal (2024) Vol. 16, Iss. 1, pp. 50-58
Open Access
Carrie A. Forman, Shari R. Lipner
Indian Dermatology Online Journal (2024) Vol. 16, Iss. 1, pp. 50-58
Open Access
